drugset / Trial / NCT05133076

Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications

NCT05133076 ↗

Phase 2 Completed 14 enrolled BioGaia Pharma AB BioFortis · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess safety and preliminary efficacy of BGP345A in patients with constipation due to the use of opioid-based medications for the management of chronic non cancer pain.

Timeline

Start
2022-01-20
Primary completion
2024-12-12
Completion
2024-12-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lactobacillus gasseri BGP345A Unknown — Oral